← Back to Search

Open-Source Hearing Aids for Hearing Loss (COSP-1 Trial)

N/A
Waitlist Available
Led By Varsha H Rallapalli, AuD, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Sensorineural hearing loss with pure-tone thresholds between 25-85 decibel hearing level (dB HL) at octave frequencies between 250 and 3000 Hz
Normal or corrected-to-normal vision
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (1 day)
Awards & highlights

COSP-1 Trial Summary

This trial seeks to bridge the gap between commercial hearing aids and research, creating an open-source platform. It will be evaluated to enable lab and field applications, and all activities will take place at Northwestern University.

Who is the study for?
This trial is for adults over 18 with sensorineural hearing loss, who speak English as their primary language and have normal or corrected vision. They should be in good health overall. People with unstable medical conditions, cognitive impairment (scoring below 23 on a specific test), conductive hearing loss, or significant ear/neurological disorders cannot participate.Check my eligibility
What is being tested?
The study is testing two versions of an open-source speech platform (OSP) designed to improve research into hearing aids: one that's portable and another that's cloud-based. The goal is to see how these platforms can support lab and field work in audiology research at Northwestern University.See study design
What are the potential side effects?
Since this trial involves non-invasive technology rather than medication, traditional side effects are not expected. However, participants may experience discomfort from wearing the device or fatigue during testing procedures.

COSP-1 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have hearing loss within a specific range.
Select...
My vision is normal or corrected to normal.

COSP-1 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (1 day)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Word-identification ability
Secondary outcome measures
Phoneme confusions
Response time

COSP-1 Trial Design

2Treatment groups
Experimental Treatment
Group I: Portable OSPExperimental Treatment1 Intervention
Outcomes will be assessed with the portable version of the OSP.
Group II: Cloud-based OSPExperimental Treatment1 Intervention
Outcomes will be assessed with the cloud-based version of the OSP.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,201 Total Patients Enrolled
16 Trials studying Hearing Loss
2,006 Patients Enrolled for Hearing Loss
Nadi, LLCUNKNOWN
Varsha H Rallapalli, AuD, PhDPrincipal InvestigatorNorthwestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a call for participants in this trial at present?

"Indeed, according to clinicaltrials.gov, this research is still open for patient recruitment and has been since it was first published on June 1st 2023. The trial requires 30 patients from a single location and its most recent update was made on November 11th of the same year."

Answered by AI

What is the current enrollment size for this research project?

"Affirmative. On clinicaltrials.gov, the details for this medical trial demonstrate that it is currently accepting patients. Initially posted on June 1st 2023 and recently updated on November 11th 2023, 30 individuals are being sought from a single research centre."

Answered by AI
~13 spots leftby Apr 2025